Inês Coelho

Dr. Inês Coelho

Hospital Amato Lusitano
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
RMRoberto Calças Marques
Roberto Calças Marques
MRMarina Reis
Marina Reis
GPGonçalo Pimenta
Gonçalo Pimenta
ISInês Sala
Inês Sala
TCTeresa Chuva
Teresa Chuva
JCJosé Maximino Costa
José Maximino Costa
Background: Acute kidney injury (AKI) is a common complication among cancer patients, often leading to longer hospital stays, discontinuation of cancer treatment, and a poor prognosis. This study aims to provide insight into the incidence of severe AKI in this population and identify the risk factors associated with renal replacement therapy (RRT) and in-hospital mortality. Methods: This retrospective cohort study included 3201 patients with cancer and severe AKI admitted to a Comprehensive Cancer Center between January 1995 and July 2023. Severe AKI was defined according to the KDIGO guidelines as grade ≥ 2 AKI with nephrological in-hospital follow-up. Data were analyzed in two timelines: Period A (1995–2010) and Period B (2011–2023). Results: A total of 3201 patients (1% of all hospitalized cases) were included, with a mean age of 62.5 ± 17.2 years. Solid tumors represented 75% of all neoplasms, showing an increasing tendency, while hematological cancer decreased. Obstructive AKI declined, whereas the incidence of sepsis-associated, prerenal, and drug-induced AKI increased. Overall, 20% of patients required RRT, and 26.4% died during hospitalization. A predictive model for RRT (AUC 0.833 [95% CI 0.817–0.848]) identified sepsis and hematological cancer as risk factors and prerenal and obstructive AKI as protective factors. A similar model for overall in-hospital mortality (AUC 0.731 [95% CI 0.71–0.752]) revealed invasive mechanical ventilation (IMV), sepsis, and RRT as risk factors and obstructive AKI as a protective factor. The model for hemato-oncological patients’ mortality (AUC 0.832 [95% CI 0.803–0.861]) included IMV, sepsis, hematopoietic stem cell transplantation, and drug-induced AKI. Mortality risk point score models were derived from these analyses. Conclusions: This study addresses the demographic and clinical features of cancer patients with severe AKI. The development of predictive models for RRT and in-hospital mortality, along with risk point scores, may play a role in the management of this population.

3 May 2021 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
FSFilipa Silva
Filipa Silva
KFKlaus Nunes Ficher
Klaus Nunes Ficher
LVLaila Viana
Laila Viana
ICInês Coelho
Inês Coelho
JRJuliana Toniato Rezende
Juliana Toniato Rezende
JPJose Medina Pestana
Jose Medina Pestana
Cytomegalovirus (CMV) retinitis is a rare manifestation of CMV invasive disease and potentially threatening to vision in immunocompromised individuals. Clinical suspicion is fundamental since it is an unusual entity with a progressive and often asymptomatic installation over a long period. The authors report a 70-year-old man with diabetic nephropathy who underwent a kidney transplant (KT) in August 2014 with good clinical evolution. No previous CMV infection or episodes of acute rejection were reported. Five years after transplant, he was admitted due to a reduced visual acuity of the left eye with seven days of evolution with associated hyperemia, without exudate. The ophthalmologic evaluation was compatible with acute necrosis of the retina and presumed associated with CMV infection. He had a progressive improvement after ganciclovir initiation. CMV retinitis is one of the most serious ocular complications in immune-suppressed individuals and can lead to irreversible blindness, and because of that, early diagnosis and treatment remains crucial in obtaining the best visual prognosis in affected patients. Secondary prophylaxis with ganciclovir is not consensual, neither is the safety of reintroducing the antimetabolite in these cases.

1 June 2019 in Transplantation Proceedings
Verified
Journal Article
Closed access
ICInês Coelho
Inês Coelho
CRC. Romãozinho
C. Romãozinho
ATA.C. Teixeira
A.C. Teixeira
LRL. Rodrigues
L. Rodrigues
EFE. Ferreira
E. Ferreira
AFArnaldo J.C. Figueiredo
Arnaldo J.C. Figueiredo

22 January 2019 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
SCSofia Cerqueira
Sofia Cerqueira
ICInês Coelho
Inês Coelho
FMFernando Macário
Fernando Macário
AFArnaldo J.C. Figueiredo
Arnaldo J.C. Figueiredo
A 39-year-old patient who had kidney transplant presented at the emergency department with pain in his right flank that was ongoing for 15 days. It had started suddenly when he was driving his taxi, after a coughing effort. No haematuria and no history of trauma. He had had a deceased donor kidney

30 May 2016 in Revista Portuguesa de Pneumologia (English Edition)
Verified
Journal Article
Open access
AFA.C. Freitas
A.C. Freitas
VLV. Lavrador
V. Lavrador
ICInês Coelho
Inês Coelho
RSR. Sousa
R. Sousa
VSV. Senra
V. Senra
LML. Morais
L. Morais

7 August 2025 in Nefrología (English Edition)
Verified
Journal Article
Open access
AFAndré Ferreira
André Ferreira
MRMarina Reis
Marina Reis
TCTeresa Chuva
Teresa Chuva
HFHugo Ferreira
Hugo Ferreira
ICInês Coelho
Inês Coelho
JCJosé Maximino Costa
José Maximino Costa
Acute kidney injury (AKI) is a frequent and severe complication in hospitalised cancer patients. However, overall data from in-hospital drug-related AKI in cancer patients is scarce. We aim to review the profile of moderate to severe drug-induced AKI in patients admitted to an oncology hospital over the last two decades and to assess renal and overall outcomes. 410 cases of drug-induced AKI KDIGO≥2 were analyzed, comparing between two decades from 2002 to 2021 in a comprehensive cancer center. The main differences were the introduction of new classes of cancer therapy (e.g., immune checkpoint inhibitors [ICPI] and tyrosine kinase inhibitors [TKI]), a decrease in nephrotoxicity due to platinum-based drugs, and an increase in nephrotoxicity caused by multiple drugs without cancer-directed therapy. Mortality was similar, but the need for haemodialysis (HD) was higher in the second decade (25.5% vs 36.6%, p=0.02). Multivariate analysis presented invasive mechanical ventilation and sepsis as risk factors for both HD and mortality, haematologic cancer as risk factors for HD, and the need for HD and multiple drugs without cancer-directed therapy as risk factors for mortality. Adequate drug surveillance and prophylaxis render cancer therapy as a relatively small contributor to drug-induced AKI in a comprehensive cancer center. Critically ill patients have a higher need for HD and mortality regardless of the nephrotoxic agent implied.